Herpes simplex encephalitis: A review

Heart and Lung: Journal of Acute and Critical Care

Volumn 27, Issue 3, 1998, Pages 209-212

  Levitz, Robert E ^a  

^a HARTFORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; DNA POLYMERASE; HERPES SIMPLEX VACCINE; PROTEIN; VIDARABINE; VIRUS ANTIBODY; VIRUS DNA;

BRAIN BIOPSY; BRAIN SCINTISCANNING; CEREBROSPINAL FLUID EXAMINATION; CESAREAN SECTION; CLINICAL FEATURE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; ELECTROENCEPHALOGRAPHY; GENITAL HERPES; HAND WASHING; HERPES SIMPLEX ENCEPHALITIS; HERPES SIMPLEX VIRUS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; NEUROTOXICITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SOUTHERN BLOTTING; VIRUS CULTURE;

EID: 0031808590     PISSN: 01479563     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0147-9563(98)90009-7     Document Type: Article

References (27)

1. Sköldenberg B. Herpes simplex encephalitis. Scand J Infect Dis Suppl 1991;78:40-6.
2. Whitley RJ, Soong S-J, Dolin R, Galasso GJ, Ch'ien LT, Alford CA. Adenine arabinoside therapy of biopsy-proved herpes simplex encephalitis: NIAID Collaborative Antiviral Study. N Engl J Med 1977;297:289-94.
3. Whitley RJ, Alford CA, et al. Vidarabine versus acyclovir therapy in herpes simplex encephalitis: NIAID Collaborative Antiviral Study Group. N Engl J Med 1986;314:144-9.
4. Whitley RJ, Lakeman F. Herpes simplex virus infections of the central nervous system: therapeutic and diagnostic considerations. Clin Infect Dis 1995;20:414-20.
5. Whitley RJ, Soong S-J, Linneman C Jr, Liu C, Pazin G, Alford CA. Herpes simplex encephalitis: clinical assessment: NIAID Collaborative Antiviral Study Group. JAMA 1982;247:317-20.
6. Corey L, Adams HG, Brown ZA, Holmes KK. Genital herpes simplex virus infection: clinical manifestations, course, and complications. Ann Intern Med 1983;98:958-72.
7. Sawyer J, Ellner J, Ransohoff D. To biopsy or not to biopsy in suspected herpes simplex encephalitis: a quantitative analysis. Med Decis Making 1988;8:95-101.
8. Levine DP, Laute CB, Oerner AM. Simultaneous serum and CSF antibodies in herpes simplex virus encephalitis. JAMA 1978;240:356-60.
9. Morawetz R, Whitley RJ, Murphy D. Experience with brain biopsy for suspected herpes encephalitis: a review of forty consecutive cases. Neurosurgery 1983;12:654-7.
10. Schroth G, Gawehn J, Thron A, Vallbracht A, Voigt K. Early diagnosis of herpes simplex encephalitis by MRI. Neurology 1987;37:179-83.
11. Soong S-J, Watson NE, Caddell GR, Alford CA Jr, Whitley RJ. Use of brain biopsy for diagnostic evaluation of patients with suspected herpes simplex encephalitis: a statistical model and its clinical implications: NIAID Collaborative Antiviral Study Group. J Infect Dis 1991;163:17-22.
12. Lakeman FD, Whitley RJ. Diagnosis of herpes simplex encephalitis: application of polymerase chain reaction to cerebrospinal fluid from brain-biopsied patients and correlation with disease: NIAID Collaborative Antiviral Study Group. J Infect Dis 1995;171:857-63.
13. Guffond T, Dewilde A, Lobert P-E, Caparros-Lefebvre C, Hober D, Wattre P. Significance and clinical relevance of the detection of herpes simplex virus DNA by the polymerase chain reaction in cerebrospinal fluid from patients with presumed encephalitis. Clin Infect Dis 1994;18:744-9.
14. Dorsky DI, Crumpacker CS. Drugs five years later: acyclovir. Ann Intern Med 1987;107:859-74.
15. Kimura H, Aso K, Kuzushima K, Hanada N, Shibata M, Morrishima T. Relapse of herpes simplex encephalitis in children. Pediatrics 1992;89:891-4.
16. Rothman A, Cheeseman SH, Lehrman SN. Herpes simplex encephalitis in a patient with lymphoma: relapse following acyclovir therapy. JAMA 1988;259:1056-7.
17. VanLandingham KE, Marsteller HB, Ross GW. Relapse of herpes simplex encephalitis after conventional acyclovir therapy. JAMA 1988;259:1051-3.
18. Quintiliani R, Levitz RE. Herpes simplex encephalitis: the case against brain biopsy [letter]. J Infect Dis 1991;164:426.
19. Prober CG, Arvin AM. Commentary: perinatal herpes - current status and obstetric management strategies: the pediatric perspective. Pediatr Infect Dis J 1995;14:832-5.
20. Brown ZA, Vontver LA, Beneditti J, Critchlow CW, Seils CJ, Berry S, et al. Effects on infants of a first episode of genital herpes during pregnancy. N Engl J Med 1987;317:1246-51.
21. Prober CG, Sullender WM, Yasukawa LL, Au DS, Yeager AS, Arvin AM. Low risk of herpes simplex virus infections in neonates exposed to the virus at the time of vaginal delivery to mothers with recurrent genital herpes simplex virus infections. N Engl J Med 1987;316:240-4.
22. Whitley R, Arvin A, Prober C, Burchett S, Corey L, Powell D, et al. A controlled trial comparing vidarabine with acyclovir in neonatal herpes simplex virus infection. N Engl J Med 1991;324:444-9.
23. Scott LL, Sanchez PI, Jackson GL, Zeray F, Wendell GD Jr. et al. Acyclovir suppression to prevent cesarean delivery after first-episode genital herpes. Obstet Gynecol 1996;87:69-73.
24. Arvin AM, Hensleigh PA, Prober CG, Au DS, Yasukawa LL, Wittek AE, et al. Failure of antepartum maternal cultures to predict the infant's risk of exposure to herpes simplex virus at delivery. N Engl J Med 1986;315:796-800.
25. Prober CG, Hensleigh PA, Boucher FD, Yasukawa LL, Au DS, Arvin AM. Use of routine viral cultures at delivery to identify neonates exposed to herpes simplex virus. N Engl J Med 1988;318:887-91.
26. Langenberg AG, Burke RL, Adair SF, Sekulovich R, Tigges M, Dekker CL, et al. A recombinant glycoprotein vaccine for herpes simplex virus type 2: safety and immunogenicity. Ann Intern Med 1995;122:889-98.
27. Connelly BL, Stanberry LR. Herpes simplex virus infections in children. Curr Opin Pediatr 1995;7:19-23.